If past is prologue, while the second Trump administration is expected to take a number of actions that could lead to increased volatility ...

The addition of concurrent cisplatin to adjuvant radiation therapy conferred no benefit to women with intermediate-risk, ...

The Sudanese military recaptured the presidential palace in the capital, Khartoum, on Friday, as it continued to make ...

The growing demand for fire sprinkler systems highlights the increased focus on safety among residential and commercial ...

U.S. and Canadian biofuel companies are throttling back production to limit losses amid uncertainty over U.S. President ...

One Iowa biodiesel maker has shut down as the Trump administration's tariffs and yet-unknown policies for the sector leave ...

While new U.S. tariffs are threatening to make imported feedstocks unaffordable, uncertainty over U.S. biofuel subsidy ...

The greater the number of risk factors in patients with cutaneous squamous cell carcinoma, the higher the likelihood of poor ...

The splintering relationship between the North American neighbors could upend a multi-year biofuel industry boom that has ...

Phase III DIPPER trial shows that adjuvant camrelizumab administered after induction-concurrent chemoradiotherapy ...

Adjuvant CRT did not improve outcomes over adjuvant RT in patients with intermediate-risk, early-stage cervical cancer after radical hysterectomy.

Georgina V. Long, MD, MSc, discussed the long-term follow-up data for the combination of adjuvant dabrafenib and trametinib ...